By Metro US
Posted on
RIO DE JANEIRO (Reuters) – Brazil’s Fiocruz biomedical institute said on Tuesday it would not be able to deliver finished doses of a coronavirus vaccine developed by AstraZeneca until March due to a delayed shipment of active ingredients from China.
Initially, Fiocruz had estimated it would be able to deliver 1 million AstraZeneca doses by mid-February.
(Reporting by Pedro Fonseca)
White Sox drop to 3-22 as Julien hits 2 of Twins’ 5 homers in 6-3 win for 4-game sweep
Islanders update: Matt Martin in for Game 3 vs. Hurricanes
QB Jaden Rashada transfers to Georgia after leaving Arizona State
Charlie Woods, son of Tiger, shoots 81 in local qualifier and fails in bid to play in US Open
Massive policing for Paris Olympics to include security checks for some of the capital’s residents
Ukraine pulls US-provided Abrams tanks from the front lines over Russian drone threats
US expected to provide $6 billion to fund long-term weapons contracts for Ukraine, officials say
New York City to require warning labels for sugary foods and drinks in chain restaurants
Selling weight-loss and muscle-building supplements to minors in New York is now illegal
NASA astronauts arrive for Boeing’s first human spaceflight
New York City to require warning labels for sugary foods and drinks in chain restaurants
Selling weight-loss and muscle-building supplements to minors in New York is now illegal
Minneapolis smokers to pay some of the highest cigarette prices in US with a $15 per-pack minimum
UN report says 282 million people faced acute hunger in 2023, with the worst famine in Gaza
